Intervention of Engineered Immune Effector T Cells Against Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
- Status
- TERMINATED
- Phase
- PHASE2
The Pharmacokinetics and Safety of Single-dose and Parallel Comparisons in Patients With NSCLC Treated With JS001
- Status
- COMPLETED
- Phase
- PHASE1
Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection
- Status
- UNKNOWN
- Phase
- PHASE3
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
- Status
- TERMINATED
- Phase
- NA
Stereotactic Body Radiotherapy for the Treatment of OPD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
- Status
- COMPLETED
- Phase
- N/A
A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2